MedPath

Exploratory study on effectiveness and safety of long-term administration of Rikkunshito for improvement of anorexia and quality of life in patients with Parkinson's disease accompanied by apathy.

Not Applicable
Conditions
Parkinson&#39
s disease
Registration Number
JPRN-UMIN000030857
Lead Sponsor
Saitama Medical Center, Saitama Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Not provided

Exclusion Criteria

Patients applicable to any one of the following items are excluded. (1) Patients complicated of dementia (patients with MoCA-J of 25 or less) (2) Patients with depression, psychiatric symptoms (3) Patients with abnormalities judged to require treatment by brain MRI (performed within 6 months) (4) Patients who can not orally administer (5) Patients who took herbal medicine within the first month before the start of the study (6) Patients who can not discontinue combination use prohibited medicine during the observation period from two weeks before the start of the study (7) Patients complicated of serious complications (heart, liver, kidney function disorder, hematopoietic disorder, malignant tumor etc.) or other diseases judged to affect life (8) Patients allergic to traditional Chinese medicine (9) Patients judged unsuitable by research researcher or research sharing doctor However, MoCA-J of (1) is carried out twice at intervals of 4 weeks, and patients who were 25 points or less at once are excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath